Healthcare Services
Valuation | |
|---|---|
| Market Cap | 1.09 LCr |
| Price/Earnings (Trailing) | 60.58 |
| Price/Sales (Trailing) | 4.47 |
| EV/EBITDA | 30.67 |
| Price/Free Cashflow | 266.05 |
| MarketCap/EBT | 45.31 |
| Enterprise Value | 1.14 LCr |
Fundamentals | |
|---|---|
Growth & Returns | |
|---|---|
| Price Change 1W | 0.70% |
| Price Change 1M | 9.8% |
| Price Change 6M | -4.2% |
| Price Change 1Y | 18.2% |
| 3Y Cumulative Return | 18.1% |
| 5Y Cumulative Return | 21.1% |
| 7Y Cumulative Return | 30.9% |
| 10Y Cumulative Return | 18.2% |
| Revenue (TTM) |
| 24.42 kCr |
| Rev. Growth (Yr) | 16.8% |
| Earnings (TTM) | 1.87 kCr |
| Earnings Growth (Yr) | 36.1% |
Profitability | |
|---|---|
| Operating Margin | 10% |
| EBT Margin | 10% |
| Return on Equity | 19.53% |
| Return on Assets | 8.5% |
| Free Cashflow Yield | 0.38% |
Cash Flow & Liquidity |
|---|
| Cash Flow from Investing (TTM) | -3.38 kCr |
| Cash Flow from Operations (TTM) | 2.14 kCr |
| Cash Flow from Financing (TTM) | 1.32 kCr |
| Cash & Equivalents | 488.4 Cr |
| Free Cash Flow (TTM) | 423.7 Cr |
| Free Cash Flow/Share (TTM) | 29.47 |
Balance Sheet | |
|---|---|
| Total Assets | 21.95 kCr |
| Total Liabilities | 12.4 kCr |
| Shareholder Equity | 9.55 kCr |
| Current Assets | 8.02 kCr |
| Current Liabilities | 4.76 kCr |
| Net PPE | 9.96 kCr |
| Inventory | 505.4 Cr |
| Goodwill | 1.03 kCr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.24 |
| Debt/Equity | 0.56 |
| Interest Coverage | 4.41 |
| Interest/Cashflow Ops | 5.74 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 20 |
| Dividend Yield | 0.26% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Balance Sheet: Strong Balance Sheet.
Past Returns: In past three years, the stock has provided 18.1% return compared to 12.6% by NIFTY 50.
Profitability: Recent profitability of 8% is a good sign.
Technicals: Bullish SharesGuru indicator.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Growth: Good revenue growth. With 53% growth over past three years, the company is going strong.
Size: It is among the top 200 market size companies of india.
Smart Money: Smart money has been increasing their position in the stock.
No major cons observed.
Balance Sheet: Strong Balance Sheet.
Past Returns: In past three years, the stock has provided 18.1% return compared to 12.6% by NIFTY 50.
Profitability: Recent profitability of 8% is a good sign.
Technicals: Bullish SharesGuru indicator.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Growth: Good revenue growth. With 53% growth over past three years, the company is going strong.
Size: It is among the top 200 market size companies of india.
Smart Money: Smart money has been increasing their position in the stock.
No major cons observed.
Investor Care | |
|---|---|
| Dividend Yield | 0.26% |
| Dividend/Share (TTM) | 20 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 125.33 |
Financial Health | |
|---|---|
| Current Ratio | 1.68 |
| Debt/Equity | 0.56 |
Technical Indicators | |
|---|---|
| RSI (14d) | 88.12 |
| RSI (5d) | 63.61 |
| RSI (21d) | 76.56 |
| MACD Signal | Buy |
| Stochastic Oscillator Signal | Sell |
| SharesGuru Signal | Buy |
| RSI Signal | Sell |
| RSI5 Signal | Hold |
| RSI21 Signal | Sell |
| SMA 5 Signal | Sell |
| SMA 10 Signal |
Updated May 4, 2025
The stock is trading 0.55% lower and has seen a year-to-date decline of 4.38%.
Mutual fund and foreign institutional investor holdings have decreased to 12.77% and 45.27%, respectively.
The company's TTM P/E ratio of 80.08 is significantly higher than the sector average of 23.01, raising concerns about its valuation.
Summary of Apollo Hospitals Enterprises's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Understand Apollo Hospitals Enterprises ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| M/s. PCR Investments Ltd | 18.93% |
| GOVERNMENT OF SINGAPORE | 2.34% |
| MIRAE ASSET ELSS TAX SAVER FUND | 2.13% |
| Ms. Suneeta Reddy | 2.04% |
| AXIS MUTUAL FUND TRUSTEE LIMITED | 1.82% |
| Ms. Sangita Reddy | 1.69% |
| Ms. Shobana Kamineni | 1.56% |
Detailed comparison of Apollo Hospitals Enterprises against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| MAXHEALTH | Max Healthcare Institute | 1.05 LCr | 8.3 kCr | +8.90% | +6.10% | 74.07 | 12.67 | - | - |
| FORTIS | Fortis Healthcare | 68.44 kCr |
Comprehensive comparison against sector averages
APOLLOHOSP metrics compared to Healthcare
| Category | APOLLOHOSP | Healthcare |
|---|---|---|
| PE | 60.58 | 61.98 |
| PS | 4.47 | 6.30 |
| Growth | 14.6 % | 16.9 % |
Apollo Hospitals Enterprises is a prominent healthcare company based in Chennai, India, with the stock ticker APOLLOHOSP and a market capitalization of Rs. 101,296.5 Crores. The company was established in 1979 and operates both domestically and internationally in various segments of healthcare.
Core Operations
Apollo Hospitals Enterprise Limited, along with its subsidiaries, provides a broad range of healthcare services through several segments, including:
Its healthcare facilities deliver primary, secondary, and tertiary care, along with a variety of specialty services. Some key areas of specialization include:
Additionally, the company offers numerous other healthcare services in fields like cardiology, neurology, gastroenterology, and more.
Service Offerings
Apollo Hospitals Enterprises also provides:
It manages various healthcare establishments, including pharmacies, clinics, dialysis centers, and specialized health centers. Notably, it engages in bio-banking of tissues and runs Apollo 24/7, a digital health mobile platform.
Financial Performance
The company has reported a trailing twelve months revenue of Rs. 21,313 Crores, demonstrating significant growth of 51.7% over the past three years. Apollo Hospitals Enterprises also returns value to its shareholders, distributing dividends with a yield of 0.35% per year, amounting to Rs. 25 per share in the last 12 months.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
| Buy |
| SMA 20 Signal | Buy |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
APOLLOHOSP vs Healthcare (2021 - 2026)
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Apollo Hospitals Enterprise has shown a robust five-year performance with an increase of 406.03%.
Analyst / Investor Meet • 14 Feb 2026 as per annexure enclosed |
Analyst / Investor Meet • 12 Feb 2026 as per annexure enclosed |
Analyst / Investor Meet • 10 Feb 2026 as per annexure enclosed |
Investor Presentation • 10 Feb 2026 as per annexure enclosed |
Acquisition • 10 Feb 2026 As per annexure enclosed |
Analyst / Investor Meet • 30 Jan 2026 As per annexure enclosed |
This information is AI-generated and may contain inaccuracies. Please verify from multiple sources.
| SBI NIFTY 50 ETF | 1.55% |
| ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED | 1.45% |
| NIPPON LIFE INDIA TRUSTEE LTD | 1.32% |
| INVESCO INDIA CONTRA FUND | 1.2% |
| FRANKLIN INDIA FLEXI CAP FUND | 1.14% |
| Mr. K Vishweshwar Reddy | 1.1% |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND | 1.01% |
| Ms. Preetha Reddy | 0.73% |
| Ms. Sindoori Reddy | 0.22% |
| Ms. Anuspala Kamineni | 0.18% |
| Dr. Prathap C Reddy | 0.17% |
| Mr. Vijay Kumar Reddy | 0.16% |
| Mr. Konda Anindith Reddy | 0.16% |
Distribution across major stakeholders
Distribution across major institutional holders
| 8.84 kCr |
| +5.90% |
| +50.10% |
| 71.27 |
| 7.75 |
| - |
| - |
| NH | Narayana Hrudayalaya | 37.55 kCr | 6.88 kCr | +1.00% | +33.70% | 47.92 | 5.46 | - | - |
| MEDANTA | Global Health | 30.63 kCr | 4.27 kCr | +6.00% | -0.80% | 59.61 | 7.18 | - | - |
| KIMS | Krishna Institute of Medical Sciences | 28.04 kCr | 3.65 kCr | +13.60% | +30.40% | 93.43 | 7.69 | - | - |
| LALPATHLAB | Dr. Lal Pathlabs | 23.6 kCr | 2.77 kCr | +2.30% | +7.80% | 44.48 | 8.53 | - | - |
| METROPOLIS | Metropolis Healthcare | 9.84 kCr | 1.59 kCr | -0.50% | +15.20% | 58.35 | 6.19 | - | - |
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
| 2.7% |
| 5,844 |
| 5,690 |
| 5,313 |
| 5,148 |
| 5,060 |
| 5,076 |
| Profit Before exceptional items and Tax | 2.7% | 686 | 668 | 569 | 505 | 531 | 552 |
| Exceptional items before tax | - | -19.2 | 0 | 0 | 0 | 0 | 0 |
| Total profit before tax | -0.1% | 667 | 668 | 569 | 505 | 531 | 552 |
| Current tax | -9.3% | 147 | 162 | 125 | 119 | 134 | 160 |
| Deferred tax | 0% | 19 | 19 | 17 | -18 | 22 | 1.9 |
| Total tax | -8.3% | 166 | 181 | 142 | 101 | 157 | 162 |
| Total profit (loss) for period | 4.5% | 516 | 494 | 441 | 414 | 379 | 396 |
| Other comp. income net of taxes | -102.1% | -0.2 | 57 | 5.9 | -3 | -2.9 | -5.5 |
| Total Comprehensive Income | -6.4% | 516 | 551 | 447 | 412 | 376 | 390 |
| Earnings Per Share, Basic | 5.4% | 34.94 | 33.19 | 30.1 | 27.1 | 25.89 | 26.34 |
| Earnings Per Share, Diluted | 5.4% | 34.94 | 33.19 | 30.1 | 27.1 | 25.89 | 26.34 |
| 12.1% |
| 1,597 |
| 1,425 |
| 1,239 |
| 1,150 |
| 1,275 |
| 1,519 |
| Finance costs | 1.6% | 254 | 250 | 239 | 244 | 344 | 426 |
| Depreciation and Amortization | 12.6% | 449 | 399 | 367 | 363 | 436 | 482 |
| Other expenses | 12.7% | 2,313 | 2,052 | 1,743 | 1,599 | 1,573 | 1,678 |
| Total Expenses | 12% | 6,861 | 6,125 | 5,449 | 5,286 | 8,985 | 9,287 |
| Profit Before exceptional items and Tax | 27% | 1,688 | 1,329 | 1,228 | 859 | 186 | 518 |
| Exceptional items before tax | - | 0 | 0 | 0 | -6.74 | -9.09 | 164 |
| Total profit before tax | 27% | 1,688 | 1,329 | 1,228 | 852 | 177 | 682 |
| Current tax | 26.2% | 406 | 322 | 302 | 40 | 62 | 205 |
| Deferred tax | -217.8% | -13.3 | -3.5 | -159.77 | 239 | 9.48 | 6.94 |
| Total tax | 23.3% | 392 | 318 | 143 | 280 | 72 | 212 |
| Total profit (loss) for period | 28.3% | 1,296 | 1,010 | 1,085 | 665 | 105 | 470 |
| Other comp. income net of taxes | 91.6% | 0.2 | -8.5 | -11.14 | -2.24 | -5.58 | 0.75 |
| Total Comprehensive Income | 29.4% | 1,296 | 1,002 | 1,074 | 663 | 100 | 471 |
| Earnings Per Share, Basic | 28.7% | 90.15 | 70.28 | 75.45 | 46.26 | 7.51 | 33.8 |
| Earnings Per Share, Diluted | 28.7% | 90.15 | 70.28 | 75.45 | 46.26 | 7.51 | 33.8 |
| Debt equity ratio | - | - | - | 025 | - | 082 | 082 |
| Debt service coverage ratio | - | - | - | 0.0231 | - | 0.0292 | 0.0292 |
| Interest service coverage ratio | - | - | - | 0.0713 | - | 0.0427 | 0.0427 |
| 1% |
| 6,299 |
| 6,239 |
| 5,953 |
| 5,971 |
| 5,355 |
| 5,049 |
| Capital work-in-progress | 32.8% | 390 | 294 | 295 | 172 | 97 | 89 |
| Goodwill | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-current investments | 1.9% | 2,525 | 2,479 | 2,467 | 1,938 | 1,938 | 1,925 |
| Loans, non-current | 25.7% | 539 | 429 | 360 | 245 | 225 | 236 |
| Total non-current financial assets | 4.9% | 3,212 | 3,061 | 2,985 | 2,361 | 2,400 | 2,292 |
| Total non-current assets | 2.9% | 10,135 | 9,854 | 9,478 | 8,730 | 7,994 | 7,630 |
| Total assets | 5.9% | 14,167 | 13,372 | 12,850 | 12,405 | 11,500 | 10,780 |
| Borrowings, non-current | 2.1% | 1,586 | 1,554 | 1,681 | 1,786 | 1,621 | 1,520 |
| Total non-current financial liabilities | 2% | 2,889 | 2,833 | 2,841 | 2,944 | 2,577 | 2,225 |
| Total non-current liabilities | 2.1% | 3,263 | 3,197 | 3,216 | 3,324 | 2,949 | 2,612 |
| Borrowings, current | -9.2% | 209 | 230 | 205 | 170 | 175 | 240 |
| Total current financial liabilities | 10.1% | 1,300 | 1,181 | 1,207 | 1,161 | 1,035 | 1,062 |
| Provisions, current | 9.4% | 140 | 128 | 123 | 101 | 123 | 77 |
| Total current liabilities | 10.3% | 1,589 | 1,441 | 1,444 | 1,370 | 1,257 | 1,243 |
| Total liabilities | 4.6% | 4,852 | 4,638 | 4,659 | 4,694 | 4,206 | 3,856 |
| Equity share capital | 0% | 72 | 72 | 72 | 72 | 72 | 72 |
| Total equity | 6.7% | 9,315 | 8,734 | 8,190 | 7,711 | 7,294 | 6,925 |
| Total equity and liabilities | 5.9% | 14,167 | 13,372 | 12,850 | 12,405 | 11,500 | 10,780 |
| 38.4% |
| 2,104 |
| 1,521 |
| 1,548 |
| 1,299 |
| - |
| - |
| Income taxes paid (refund) | 9.7% | 362 | 330 | 323 | 98 | - | - |
| Net Cashflows From Operating Activities | 46.3% | 1,742 | 1,191 | 1,224 | 1,201 | - | - |
| Cashflows used in obtaining control of subsidiaries | - | 543 | 0 | 0 | 0 | - | - |
| Proceeds from sales of PPE | 12900% | 14 | 1.1 | 2.33 | 4.99 | - | - |
| Purchase of property, plant and equipment | 38.2% | 858 | 621 | 396 | 463 | - | - |
| Proceeds from sales of long-term assets | -100.1% | 0 | 817 | 0 | 0 | - | - |
| Purchase of other long-term assets | -100.1% | 0 | 1,180 | 0 | 0 | - | - |
| Cash receipts from repayment of advances and loans made to other parties | 1133.3% | 186 | 16 | 16 | 12 | - | - |
| Dividends received | 74.3% | 177 | 102 | 61 | 0.39 | - | - |
| Interest received | 216.7% | 58 | 19 | 24 | 21 | - | - |
| Other inflows (outflows) of cash | -970% | -294.8 | 35 | 129 | -28.34 | - | - |
| Net Cashflows From Investing Activities | -25.2% | -1,045.7 | -835.3 | -588.23 | -444.6 | - | - |
| Proceeds from borrowings | -100.2% | 0 | 464 | 150 | 401 | - | - |
| Repayments of borrowings | -35.8% | 173 | 269 | 414 | 658 | - | - |
| Payments of lease liabilities | 10.1% | 110 | 100 | 85 | 0 | - | - |
| Dividends paid | 26.5% | 273 | 216 | 255 | 43 | - | - |
| Interest paid | 4% | 183 | 176 | 175 | 248 | - | - |
| Net Cashflows from Financing Activities | -148.4% | -739.1 | -297 | -778.62 | -637.22 | - | - |
| Net change in cash and cash eq. | -175.7% | -42.9 | 59 | -142.62 | 119 | - | - |
Analysis of Apollo Hospitals Enterprises's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.
Last Updated: Dec 31, 2025
| Description | Share | Value |
|---|---|---|
| a) Healthcare services | 49.5% | 3.2 kCr |
| c) Digital health and pharmacy distribution | 43.4% | 2.8 kCr |
| b) Retail health and diagnostics | 7.2% | 466.8 Cr |
| Total | 6.5 kCr |